Proteasome subunit beta type-9
Also known as: LMP2, PSMB6i, PSMB9, RING12
Function
The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. Replacement of PSMB6 by PSMB9 increases the capacity of the immunoproteasome to cleave model peptides after hydrophobic and basic residues.
Classification
- Family (Pfam)
- PF00227 Proteasome
- InterPro
- Ntn_hydrolases_N, Pept_T1A_subB, Proteasome_bsu_CS, Proteasome_sua/b, Proteasome_suB-type
- Functional cluster
- Tubulins & Mitochondrial Metabolic Enzymes
Experimental structures · PDB · 7
- 6AVO EM 3.80A
- 6E5B X-ray 2.77A
- 7AWE X-ray 2.29A
- 7B12 X-ray 2.43A
- 9FRW X-ray 2.85A
- 9FST X-ray 2.75A
- 9FSU X-ray 2.75A
A predicted model is available from AlphaFold.
Gene Ontology · 22
- GO:0005829 cytosol
- GO:0070062 extracellular exosome
- GO:0005634 nucleus
- GO:0000502 proteasome complex
- GO:0005839 proteasome core complex
- GO:0019774 proteasome core complex, beta-subunit complex
- GO:1990111 spermatoproteasome complex
- GO:0004175 endopeptidase activity
- GO:0004298 threonine-type endopeptidase activity
- GO:0043374 CD8-positive, alpha-beta T cell differentiation
- GO:0160165 CD8-positive, alpha-beta T cell homeostasis
- GO:0002376 immune system process
- GO:0045590 negative regulation of regulatory T cell differentiation
- GO:0032743 positive regulation of interleukin-2 production
- GO:0032760 positive regulation of tumor necrosis factor production
- GO:0032729 positive regulation of type II interferon production
- GO:0010498 proteasomal protein catabolic process
- GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process
- GO:0034341 response to type II interferon
- GO:0045063 T-helper 1 cell differentiation
- GO:0072539 T-helper 17 cell differentiation
- GO:0045061 thymic T cell selection
Disease associations
- proteasome-associated autoinflammatory syndrome 3 MONDO:0054699
- proteasome-associated autoinflammatory syndrome 6 MONDO:0968983
Drugs targeting this protein · 7
- OPROZOMIB inhibitor
- IXAZOMIB inhibitor
- BORTEZOMIB inhibitor
- IXAZOMIB CITRATE inhibitor
- MARIZOMIB inhibitor
- CARFILZOMIB inhibitor
- BORTEZOMIB D-MANNITOL inhibitor
Related proteins · sequence + function similarity
- Proteasome subunit beta type-9 0.99
- Proteasome subunit beta type-9 0.99
- Proteasome subunit beta type-9 0.99
- Proteasome subunit beta type-9 0.99
- Proteasome subunit beta type-9 0.99
- Proteasome subunit beta type-9 0.98
- Proteasome subunit beta type-9 0.98
- Proteasome subunit beta type-9 0.93
- Proteasome subunit beta type-6 0.92
- Proteasome subunit beta type-9 0.92
- Proteasome subunit beta type-9 0.92
- Proteasome subunit beta type-6 0.92
Co-cited proteins · studied together in the literature
- Proteasome subunit beta type-8 15 shared papers
- Proteasome subunit beta type-10 7 shared papers
- Cytotoxic T-lymphocyte protein 4 1 shared papers
- Proteasome maturation protein 2 shared papers
- Proteasome subunit beta type-9 2 shared papers
- Proteasome subunit beta type-5 3 shared papers
- HLA class II histocompatibility antigen, DO beta chain 2 shared papers
- Proteasome subunit beta type-8 2 shared papers
- Proteasome subunit beta type-4 3 shared papers
- Interferon gamma 1 shared papers
- Proteasome subunit alpha type-3 3 shared papers
- Protein tyrosine phosphatase type IVA 1 1 shared papers
Literature · 27 cited papers
- Heterozygous missense variant of the proteasome subunit beta-type 9 causes neonatal-onset autoinflammation and immunodeficiency. Nat. Commun. · 2021
- Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor. J. Allergy Clin. Immunol. · 2021
- PMID 26829627 J. Clin. Invest. · 2016
- Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production. J. Clin. Invest. · 2015
- Initial characterization of the human central proteome. BMC Syst. Biol. · 2011
- Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science · 2009
- CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1. Mol. Cell. Biol. · 2008
- Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm. Bowel Dis. · 2007
- Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes. J. Immunol. · 2006
- The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription. EMBO J. · 2006
- IRF-1 mediates upregulation of LMP7 by IFN-gamma and concerted expression of immunosubunits of the proteasome. FEBS Lett. · 2005
- Potential effects of tetrodotoxin exposure to human glial cells postulated using microarray approach. Toxicon · 2004
- … and 15 more in the literature graph
A document in the lmmol reference corpus — open public data (UniProt, GO, PDB, the literature graph) rendered as a single cross-linked page. Hover any link to preview its target.